Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2009-09-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conversion disorder
conversion disorder
Proinflammatory cytokine levels in conversion disorder
Healthy control
conversion disorder
Proinflammatory cytokine levels in conversion disorder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
conversion disorder
Proinflammatory cytokine levels in conversion disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Neurological disease
* Any organic disorder that could possibly affect proinflammatory cytokines
* Pregnancy
* Any drug usage within 2 weeks
* Any active or passive immunization within 6 months
* Any other DSM-IV axis I psychiatric disorder
* Mental retardation
* Developmental disorder of childhood
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trakya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Trakya University Scientific Research Unit (TUBAB)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Trakya University Faculty of Medicine; Department of Psychiatry
Edirne, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001 Dec 31;105(3):165-74. doi: 10.1016/s0165-1781(01)00338-9.
Ziemssen T, Kern S. Psychoneuroimmunology--cross-talk between the immune and nervous systems. J Neurol. 2007 May;254 Suppl 2:II8-11. doi: 10.1007/s00415-007-2003-8.
Dantzer R. Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology. 2005 Nov;30(10):947-52. doi: 10.1016/j.psyneuen.2005.03.011.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TUTFEK 2009/173
Identifier Type: -
Identifier Source: org_study_id